Business

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

How This Business Actually Works

Waaree is India's largest solar PV module manufacturer — a high-volume assembly business riding a structural demand wave. The economic engine is simple: buy solar cells (mostly imported from non-Chinese sources), glass, aluminum frames, and encapsulants; assemble them into modules at five Indian factories plus a US facility; sell to utilities, IPPs, C&I customers, retail rooftop buyers, and export markets. The company is transitioning from a pure assembler to a vertically integrated player — backward into cells (5.4 GW operational), ingots and wafers (10 GW planned by FY27), and forward into EPC, inverters, battery storage, and green hydrogen.

What actually drives incremental profit is not just volume — it's the mix. Three margin layers exist: (1) basic non-DCR modules for institutional domestic buyers at ~18-19% EBITDA margins, (2) DCR (Domestic Content Requirement) modules using Waaree's own cells at 300-350 bps higher margins, and (3) export modules to the US at 26-30 cents/Wp realization versus 16-17 cents domestic, plus IRA manufacturing credits at 7 cents/Wp. As own-cell capacity ramps and the DCR share grows, the blended margin structurally improves — which explains the OPM expanding from 4% in FY21 to 25% in Q3 FY26.

The revenue trajectory is extraordinary — from $26M in FY20 to $169M in FY25, a 49% sales CAGR — but what matters more is that margins expanded simultaneously. This is not a commodity assembler chasing volume; it's a manufacturer gaining operating leverage, product mix improvement, and backward integration benefits all at once.

The margin step-up from ~14-15% to 23-25% is not cyclical noise — it reflects own-cell integration, higher DCR mix, scale leverage from 1 GW/month production, and improving US profitability. Management's FY26 EBITDA guidance of $64-70M is being surpassed; 9M FY26 EBITDA already touched $51M.

The Playing Field

Waaree's dominance is a function of scale, not technology. In a market where India's total module capacity has surged from 38 GW (Mar 2023) to over 200 GW (Dec 2025), what separates the winner is execution speed, order book depth, and the ability to integrate backward into cells at scale.

What the peer set reveals:

Premier Energies is the closest pure-play comparator and the one to watch. Higher OPM (27%) and ROCE (41%) than Waaree, driven by cell-first strategy and dominant position in solar cell exports. Premier is scaling fast but at one-third of Waaree's capacity. If Premier achieves 15+ GW and closes the module gap, it becomes a genuine threat.

Vikram Solar has similar aspirations (targeting 20.5 GW by FY27) but trades at a steep premium on hope rather than execution — margins (14% OPM) significantly trail leaders. Waaree's execution advantage is widening, not narrowing.

Suzlon is not a direct competitor (wind vs solar) but competes for investor capital in India's renewable energy basket. Its turnaround is real (debt-free, 33% ROCE), but fundamentally a different business.

Waaree's advantage: 3.6x the module capacity of its nearest pure-play peer, the only Indian manufacturer with a serious US production footprint, a $640M order book providing 18+ months of revenue visibility, and an order pipeline exceeding 100 GW. The moat is not technology — Chinese panels are technically equivalent or better. The moat is policy (ALMM, DCR, BCD on imports) and scale in a protected market.

Is This Business Cyclical?

Solar module manufacturing is deeply cyclical, but the cycles are driven by policy and trade barriers, not end-demand.

Where the cycle hits:

Policy cycle (biggest driver): India's ALMM (Approved List of Module Manufacturers), BCD (Basic Customs Duty) on Chinese imports, and DCR mandates create a protected domestic market. When ALMM was temporarily suspended in 2023, module prices crashed and FY22-era margins collapsed. The policy environment is currently highly favorable: ALMM extended to cells from June 2026, DCR requirements increasing, and ingot/wafer ALMM from June 2028. This creates a multi-year tailwind — but it is government-granted and can shift.

Chinese overcapacity cycle: Global module prices collapsed 40-50% in 2023-24 as Chinese manufacturers dumped below-cost inventory. India's BCD tariff wall (40% on modules, 25% on cells) shielded domestic players, but the price floor is set by Chinese cost curves. When China's rebate policies change (export rebates on cells were eliminated in late 2025, pushing cell prices from 4-4.5 cents to 6 cents/Wp), it directly improves Indian cost competitiveness.

US trade cycle (new and dangerous): The US imposed 123% preliminary anti-dumping duties on Indian solar imports in April 2026, on top of existing ~126% countervailing duties. Total tariff burden exceeds 230%. This renders direct India-to-US module exports commercially unviable. Waaree's US factory insulates partially, but the 65% overseas share of its $640M order book is now at risk of renegotiation. Final determination expected July 2026.

Commodity cycle (manageable): Silver (under 9% of module cost), glass, and aluminum prices fluctuate but Waaree manages through back-to-back sourcing — locking input costs when orders are booked. Operating leverage offsets moderate commodity moves.

The Metrics That Actually Matter

1. OPM trajectory — The single most important metric. Module manufacturing at 4-5% OPM is a commodity slog. At 23-25% OPM, it's a high-quality industrial business. The margin expansion reflects real structural shifts (DCR mix, own cells, scale, US realization), not one-time factors. If OPM reverts below 18%, the thesis breaks.

2. Cell capacity utilization — Waaree's 5.4 GW cell facility is the key to the DCR story. Q3 FY26 averaged 56% but the exit rate hit 80%. Management is upgrading to G12R cells, targeting 85-90% utilization. Every percentage point of cell utilization directly feeds into higher-margin DCR module sales and reduces dependence on imported cells.

3. Order book to revenue ratio — At $640M against TTM revenue of $258M, the book provides 2.7x coverage. More importantly, 5-15% advances are collected on institutional orders, and retail (~20% of domestic) is cash-and-carry. The order pipeline of 100+ GW dwarfs the order book. This is not a demand-constrained business.

4. Working capital days — Negative working capital (-87 days in FY25) is the hallmark of a business that collects before it delivers. Customer advances fund operations. This is structurally powerful when combined with rapid growth — the faster Waaree grows, the more cash it generates from working capital.

5. Free cash flow vs capex — FCF turned negative (-$1.3M) in FY25 as capex surged to $80M (investing outflows). Borrowings rose from $6.6M (FY24) to $33M (H1 FY26). This is a deliberate choice: building 10 GW ingots/wafers, 15.4 GW cells, 20 GWh battery storage, 4 GW inverters, 1 GW electrolysers, and the US factory. The question is not whether capex is high — it's whether returns on these assets will match the 35% ROCE of the core business.

What I'd Tell a Young Analyst

Waaree is the clearest beneficiary of India's solar manufacturing policy wall — ALMM, BCD, and DCR collectively create a protected domestic market worth 40-50 GW of annual module demand by 2030. The company has executed brilliantly on capacity (from 2 GW to 18.7 GW in four years), margins (4% to 25% OPM), and order book ($640M). At 29x TTM earnings with 100%+ profit growth, the valuation is not absurd for a business of this quality.

What the market may be underestimating: The severity of the US trade risk. A 123% anti-dumping duty, if finalized, effectively closes the direct India-to-US export channel. Waaree's US factory provides a buffer, but 2.6 GW of US capacity is a fraction of the 65% overseas order book. The Meyer Burger acquisition signals intent to double down on US manufacturing, but execution risk is real.

What the market may be overestimating: The durability of the policy moat. India's module capacity has exploded to 200+ GW against annual installation demand of 40-50 GW. If ALMM enforcement loosens, or if 20+ manufacturers all reach scale simultaneously, pricing power evaporates. The 25% OPM is sustainable only while supply remains disciplined and policy protection holds.

Watch these triggers:

1. US anti-dumping final determination (July 2026) — binary event for the export thesis
2. Cell utilization crossing 85% sustained — validates the backward integration premium
3. Ingot/wafer commissioning by FY27 — if on time, Waaree becomes truly integrated; if delayed, capex burden rises without payoff
4. ALMM cell mandate (June 2026) — structurally positive for Waaree with India's largest cell capacity
5. Promoter holding at 64.2% with FII rising from 0.7% to 7% in one year — institutional conviction is building, but watch for supply from promoter dilution if the company needs more equity for its $160M+ capex program